RESUMEN
The so called "enzymatic preparations" Rheumajecta and Vasolastine (R & V) belong to the complementary treatments. The preparations have been used for many years in the treatment of patients with rheumatic conditions such as rheumatoid arthritis (RA) in the Netherlands and other countries of Europe, although a proper study showing efficacy was never performed. Therefore a double-blind, placebo-controlled, modified cross-over trial during two periods of 3 months was performed in 34 patients with RA. They were allocated at random to R & V or to placebo injections, all intramuscular. After 3 months of therapy each patient could opt for cross-over in the event of lack of subjective improvement. Clinical assessments including Ritchie's articular index, grip strength, the DUTCH-AIMS questionnaire, ESR and CRP were performed. R & V did not prove to be more effective than placebo. No serious side-effects were seen.
Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Catalasa/uso terapéutico , Colina O-Acetiltransferasa/uso terapéutico , Lipasa/uso terapéutico , Lipooxigenasa/uso terapéutico , Sulfato Adenililtransferasa/uso terapéutico , Sulfurtransferasas/uso terapéutico , Adolescente , Adulto , Anciano , Artritis Reumatoide/patología , Artritis Reumatoide/fisiopatología , Catalasa/administración & dosificación , Catalasa/normas , Colina O-Acetiltransferasa/administración & dosificación , Colina O-Acetiltransferasa/normas , Método Doble Ciego , Combinación de Medicamentos , Quimioterapia Combinada , Femenino , Humanos , Inyecciones Intramusculares , Lipasa/administración & dosificación , Lipasa/normas , Lipooxigenasa/administración & dosificación , Lipooxigenasa/normas , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Sulfato Adenililtransferasa/administración & dosificación , Sulfato Adenililtransferasa/normas , Sulfurtransferasas/administración & dosificación , Sulfurtransferasas/normas , Encuestas y CuestionariosRESUMEN
Rheumajecta and Vasolastine (R and V) are preparations belonging to complementary medicine. They are applied in rheumatic conditions such as primary fibromyalgia. In this double-blind, modified cross-over trial, the effect of R and V injections was compared with that of placebo over two periods of three months in 30 patients with primary fibromyalgia. No significant differences in effectiveness between R and V and placebo were seen. There were no serious side-effects. R and V are not indicated for primary fibromyalgia unless no more effect than that of placebo is intended.